CoverageForm 410-K10-Q8-K13D13G13F

COTY · Coty Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · COTY

Income Statement

Line itemQ3 '26Q2 '26Q1 '26Q2 '25Q3 '25Q1 '25Q2 '24Q3 '24Q1 '24Q2 '23
Revenue$1.28B$1.68B$1.58B$1.67B$1.30B$1.67B$1.73B$1.39B$1.64B$1.52B
Cost of Revenue$489.70M$608.00M$560.40M$555.70M$466.70M$576.90M$603.50M$487.80M$599.50M$525.30M
Gross Profit$791.90M$1.07B$1.02B$1.11B$832.40M$1.09B$1.12B$897.80M$1.04B$998.30M
R&D----------
SG&A$727.00M$842.50M$793.50M$797.30M$777.50M$808.00M$833.40M$770.60M$767.40M$754.30M
Total Operating Expenses----------
D&A$129.10M$130.10M$104.60M--$104.60M--$106.80M-
Operating Income($372.00M)$148.20M$185.00M$268.20M($280.40M)$237.80M$236.70M$77.80M$197.50M$199.30M
Interest Expense$39.60M$52.40M$51.60M$61.70M$58.80M$60.40M$61.70M$58.80M$66.80M$65.00M
Income Tax($53.20M)($52.40M)$33.10M$26.00M($58.40M)$42.00M$71.40M($5.40M)$40.90M$38.80M
Net Income($408.10M)($123.60M)$67.90M$23.70M($405.70M)$82.90M$180.90M$3.80M$1.60M$238.30M
EPS - Basic($0.47)($0.14)$0.07$0.02($0.47)$0.09$0.20$0.00$0.00$0.28
EPS - Diluted($0.47)($0.14)$0.07$0.02($0.47)$0.09$0.20$0.00$0.00$0.27

Balance Sheet

Line itemQ3 '26Q2 '26Q1 '26Q2 '25Q3 '25Q1 '25Q2 '24Q3 '24Q1 '24Q2 '23
Cash & Equivalents$257.10M$436.70M$264.60M$257.10M$243.50M$283.60M$300.80M$260.20M$280.00M$246.90M
Accounts Receivable$565.20M$689.40M$755.10M$526.40M$572.90M$703.50M$441.60M$479.90M$534.90M$360.90M
Inventory$786.30M$778.20M$807.50M$794.50M$717.30M$782.50M$764.10M$759.70M$845.40M$853.40M
Accounts Payable---$1.36B$1.28B$1.32B$1.41B$1.25B$1.38B$1.44B
Current Assets$1.94B$2.25B$2.17B$1.95B$1.93B$2.23B$1.96B$1.99B$2.24B$2.05B
Total Assets$10.23B$11.08B$12.06B$11.91B$11.47B$12.52B$12.08B$12.32B$12.62B$12.66B
Current Liabilities$2.36B$2.84B$2.55B$2.54B$2.36B$2.64B$2.60B$2.48B$2.83B$2.74B
Long-term Debt$3.17B$2.99B$4.02B$3.96B$3.80B$3.93B$3.84B$3.90B$4.10B$4.18B
Total Liabilities$6.73B$7.13B$8.00B$7.95B$7.55B$8.04B$7.83B$7.90B$8.47B$8.43B
Stockholders' Equity$3.09B$3.53B$3.64B$3.54B$3.50B$4.05B$3.83B$3.99B$3.72B$3.81B
Retained Earnings($5.74B)($5.33B)($5.20B)($5.27B)($5.20B)($4.82B)($4.90B)($4.80B)($4.99B)($4.99B)

Cash Flow

Line itemQ3 '26Q2 '26Q1 '26Q2 '25Q3 '25Q1 '25Q2 '24Q3 '24Q1 '24Q2 '23
Operating Cash Flow--$65.20M--$67.40M--$186.20M-
Investing Cash Flow--($53.80M)--($77.30M)--($62.20M)-
Financing Cash Flow--($7.60M)--($10.40M)--($78.60M)-
CapEx--$54.00M--$75.30M--$62.20M-
Free Cash Flow--$11.20M--($7.90M)--$124.00M-

Ratios

MetricQ3 '26Q2 '26Q1 '26Q2 '25Q3 '25Q1 '25Q2 '24Q3 '24Q1 '24Q2 '23
Profitability
Gross margin61.8%63.8%64.5%66.7%64.1%65.5%65.1%64.8%63.5%65.5%
Operating margin-29.0%8.8%11.7%16.1%-21.6%14.2%13.7%5.6%12.0%13.1%
EBITDA margin-19.0%16.6%18.4%--20.5%--18.5%-
Net margin-31.8%-7.4%4.3%1.4%-31.2%5.0%10.5%0.3%0.1%15.6%
Free cash flow margin--0.7%---0.5%--7.6%-
FCF / Net income--0.16---0.10--77.50-
R&D / Revenue----------
SG&A / Revenue56.7%50.2%50.3%47.7%59.8%48.3%48.2%55.6%46.8%49.5%
Effective tax rate--32.8%52.3%-33.6%28.3%-96.2%14.0%
Return on assets-4.0%-1.1%0.6%0.2%-3.5%0.7%1.5%0.0%0.0%1.9%
Return on equity-13.2%-3.5%1.9%0.7%-11.6%2.0%4.7%0.1%0.0%6.3%
Return on invested capital-4.7%1.8%1.6%1.8%-3.0%2.0%2.2%0.8%1.3%2.1%
Liquidity
Current ratio0.820.790.850.770.820.850.750.800.790.75
Quick ratio0.490.520.540.460.510.550.460.500.490.44
Cash ratio0.110.150.100.100.100.110.120.110.100.09
Leverage
Debt / Equity1.030.851.101.121.090.971.000.981.101.10
Debt / Assets0.310.270.330.330.330.310.320.320.320.33
Debt / EBITDA-10.7313.89--11.49--13.46-
Interest coverage-9.4x2.8x3.6x4.3x-4.8x3.9x3.8x1.3x3.0x3.1x
Equity multiplier3.313.143.313.363.283.093.163.093.393.32
Liabilities / Assets0.660.640.660.670.660.640.650.640.670.67
Efficiency
Asset turnover0.130.150.130.140.110.130.140.110.130.12
Inventory turnover0.620.780.690.700.650.740.790.640.710.62
Days sales outstanding161d150d175d115d161d154d93d126d119d86d
Days inventory outstanding586d467d526d522d561d495d462d568d515d593d
Days payable outstanding---896d1001d837d850d935d837d1004d
Cash conversion cycle----259d-279d-189d-295d-241d-204d-324d
Valuation
P / E--57.7x232.5x-104.3x50.1x--45.5x
P / B0.6x0.8x1.0x1.1x1.4x2.0x2.4x2.7x2.5x2.9x
P / S1.4x1.6x2.2x2.4x3.7x4.9x5.4x7.7x5.7x7.2x
EV / EBITDA-18.9x25.2x--34.7x--43.3x-
Growth
Revenue growth (YoY)-1.3%0.5%-5.6%-3.3%-6.2%1.8%13.4%7.5%18.1%-3.5%
Revenue CAGR (3y)-0.2%3.3%4.3%1.9%3.1%6.8%6.9%10.5%13.4%-13.4%
Revenue CAGR (5y)4.5%3.5%7.0%-6.6%-3.2%-3.0%-8.1%-9.0%-4.2%-
Gross profit growth (YoY)-4.9%-3.9%-7.1%-0.9%-7.3%5.1%12.6%10.7%17.2%-1.8%
Operating income growth (YoY)-32.7%-44.7%-22.2%13.3%-20.4%18.8%78.9%14.9%-18.3%
Net income growth (YoY)-0.6%--18.1%-86.9%-5081.3%-24.1%-96.5%-98.8%-8.8%
EPS growth (YoY)0.0%--22.2%-90.0%---25.9%--17.4%
EPS CAGR (3y)---22.4%-55.7%--11.5%----
EPS CAGR (5y)---21.8%--5.2%---12.5%
FCF growth (YoY)--------40.6%-
FCF CAGR (5y)----------
Book value growth (YoY)-11.5%-0.4%-9.9%-7.4%-12.5%8.7%0.4%6.8%21.9%20.8%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-06-30.

Business segments

$5.89B total
Prestige$3.82B · 64.8%
Consumer Beauty$2.07B · 35.2%

Geographic

$1.45B total
US$1.45B · 100.0%

Peer comparison

Same SIC group: Perfumes, Cosmetics & Other Toilet Preparations

CompanyRevenue (last FY)Net marginROE
EL$14.33B-7.9%-29.3%
CL$20.38B10.5%3948.1%
KVUE$15.12B9.7%13.7%
ELF$1.64B1.6%2.3%
EPC$2.22B1.1%1.6%

Comparing COTY INC. against the 5 most active filers in the same SIC group.

Dividends

$0.00/share trailing 12 months

Ex-datePer share
Feb 14, 2020$0.1250
Nov 15, 2019$0.1250
Sep 6, 2019$0.1250
Jun 5, 2019$0.1250
Feb 27, 2019$0.1250
Nov 29, 2018$0.1250
Aug 30, 2018$0.1250
May 30, 2018$0.1250
Feb 27, 2018$0.1250
Nov 29, 2017$0.1250
Aug 30, 2017$0.1250
May 26, 2017$0.1250
Feb 24, 2017$0.1250
Dec 15, 2016$0.1250
Aug 9, 2016$0.2750
Sep 29, 2015$0.2500
Sep 29, 2014$0.2000
Oct 9, 2013$0.2000